Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Entresto 24mg/26mg tablets
0205052AEBBACAC
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 30,273 |
|
Entresto 97mg/103mg tablets
0205052AEBBABAB
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 27,989 |
|
Entresto 49mg/51mg tablets
0205052AEBBAAAA
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 24,719 |
|
Entresto 15mg/16mg granules in capsules for opening
0205052AEBBAEAE
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 8 |
|
Entresto 6mg/6mg granules in capsules for opening
0205052AEBBADAD
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.